Novartis Malaysia Bags Gold for Innovative Health Heart Campaign at PR Awards Asia 2024
- Best PR campaign in Healthcare and Pharmaceuticals ‘Unblock’ing heart health for all Malaysians.
- Multi-disciplinary campaign by Novartis Malaysia actively changes the treatment paradigms of Cardiovascular Disease in Malaysia
Kuala Lumpur, June 19, 2024 - Novartis Malaysia’s unwavering commitment to changing the treatment paradigms of cardiovascular disease (CVD) outcomes in Malaysia was recognised at the recent regional level Marketing-Interactive PR Awards 2024.
The winning campaign, titled "Bending the Curve of Life: Changing the Treatment Paradigms of Cardiovascular Disease in Malaysia," won gold in the category of Best PR Campaign under Healthcare and Pharmaceuticals beating out tough competitors from across Southeast Asia, South Asia and Oceania regions.
Distinguished by its multifaceted approach, the campaign ingeniously integrated various communication channels, including digital media, traditional advertising, and community engagement initiatives. Novartis Malaysia aimed to empower individuals by equipping them with crucial knowledge about CVD risk factors, prevention measures, early detection, and innovative treatment options.
The hallmark of this groundbreaking campaign lies in the introduction of six innovative initiatives, laser-focused on raising awareness of cholesterol risk factors among Malaysians. To achieve this, Novartis Malaysia forged 14 continuous and collaborative partnerships across government agencies, healthcare professionals (HCPs), and the public.
Mohamed Elwakil, Country President of Novartis Malaysia said:
"This prestigious award serves as a testament to Novartis Malaysia's unwavering dedication in championing cholesterol awareness and transforming cardiovascular disease management in Malaysia. We believe that by fostering sustainable partnerships within the healthcare ecosystem, we can inspire collective action and drive meaningful behavioral changes towards achieving optimal heart health."
"Our aspiration is to envision a world where cardiovascular disease is effectively managed, granting patients the opportunity to live longer, healthier lives. To accomplish this, we will continue to forge productive collaborations with healthcare systems, pioneering groundbreaking approaches that challenge the status quo and disrupt the conventional treatment paradigms."
Melissa Hon, Country Communications & Patient Advocacy Head of Novartis Malaysia said:
“The prime objective of this campaign was to enhance Malaysians' understanding of the risk factors associated with an 'invisible' disease. By utilizing innovative communication channels and engaging communities, we have educated individuals about risk factors, prevention, and treatment options.
This accomplishment highlights the exceptional belief, collaboration and unwavering commitment of all stakeholders to bring their ‘A’ Game to take on a particularly challenging disease area. We extend our gratitude to our partner agencies, Acendus Communications, Afterhours Events & Marketing Services, and Eyescream Productions in supporting our purpose of improving and extending the lives of over 32 million Malaysians.”
###
About Novartis Malaysia
Novartis had a long heritage and legacy in Malaysia. Established in 1971, we are a leading multinational company employing close to 600 associates who work in the Novartis International division and Novartis Corporate Center, Kuala Lumpur. Through our over 50-year presence in Malaysia, Novartis Malaysia continues to deliver on its corporate purpose of reimagining medicine to improve and extend the lives of over 32 million Malaysians.
In 2022, Novartis Malaysia was recognized as Sponsor of the Year by Clinical Research Malaysia for initiating 24 new clinical trials. We also have a proven track record of expanding access to our innovative medicines in private or public via collaborations with the Ministry of Health Malaysia. Through these collaborations, Novartis has succeeded in touching the lives of more than 1.2 million Malaysian patients.
Novartis Malaysia’s office is located in the new cutting-edge building called Plaza Imazium in Damansara Utama, Petaling Jaya. Novartis Malaysia occupies 2 floors and was one of 20 offices in Malaysia to be LEED Gold certified and the first office to be WELL Silver certified.
About Novartis Corporate Center Kuala Lumpur
In 2015, Kuala Lumpur was selected as one of the six Novartis Corporate Centers, which is responsible for providing a broad range of services to the Novartis group of companies worldwide. It brings together expert capabilities and talent across functionalities and is an innovation hub that drives the business forward. It is home to over 400 associates who work to deliver on the Novartis purpose of reimagining medicine to improve and extend people’s lives.
Novartis Media Relations
Abby Lu
Communications and Engagement